まとめ
アセプティック性髄膜炎は,インフリキシマブで治療されたリウマチ性関節炎患者で発生し,重度の筋肉痛と一時的なリンパ球性髄膜炎として示されました. この副作用は,インフリキシマブによるものかもしれません.
科学分野:
- 神経学 神経学とは
- レウマトロジーの病理学
- 免疫学 免疫学とは
背景:
- リウマチ性関節炎 (RA) は慢性的な自己免疫疾患である.
- インフリキシマブ (infliximab) は,RAの腫瘍死滅因子αを標的とした生物学的療法です.
- 薬剤の副作用は,徹底的な調査を必要とします.
研究 の 目的:
- インフリキシマブで治療された患者の無菌性髄膜炎の症例を報告する.
- この有害反応の背後にある潜在的なメカニズムを調査する.
主な方法:
- リウマチ性関節炎を患っている53歳の男性患者の臨床症例報告.
- 抗体と炎症マーカーのための脳脊髄液の分析.
- 抗インフリキシマブ抗体と腫瘍死滅因子アルファレベルの評価.
主要な成果:
- 患者は,インフリキシマブ注入後に重度の筋肉痛と一時的なリンパ球性髄膜炎を経験しました.
- 核,DNA,またはニューロンに対する抗体は検出されなかった.
- インフリキシマブに対する機能性抗体は誘発されず,脊髄液中の腫瘍死滅因子アルファレベルも上昇しなかった.
結論:
- アセプティック性髄膜炎は,おそらく,インフリキシマブに対する副作用であった.
- インフリキシマブが中枢神経系に浸透できないことが,この反応に寄与している可能性があります.
関連する概念動画
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...